Hofseth BioCare ASA (HBC) has received the Food
Safety System Certification 22000 (FSSC 22000), which is an
ISO-based certification scheme for auditing and certification of
food safety systems in the food supply chain. The FSSC 22000
certification scheme is fully recognised and accepted by the Global
Food Safety Initiative (GFSI) and by the European co-operation for
Accreditation (EA).
After recently completing the expansion work and
recommencement of production at the Midsund plant, the FSSC 22000
standard will further secure the high-quality production of marine
ingredients at HBC from 2017.
HBC has during the fourth quarter been granted
patents on ProGo® and OmeGo® in several important markets,
including Spain, Ireland, United Kingdom, Netherlands, Switzerland,
Belgium and Germany. The patent grants for "Compositions and
Methods for Increasing Iron Absorption" on ProGo®, gives HBC the
sole marketing claim rights to for increasing iron uptake in humans
from marine protein sources in these important markets.
From January 2017, Karl Inge Slotsvik joins HBC as
new COO. Mr Slotsvik, 35, previously held several positions in
Firmenich Bjørge Biomarin AS, such as Production Manager, General
Manager and most recently Global Innovation and Business
Development Director.
-
We are delighted that Karl Inge, with his
extensive experience and contact network, decided to join HBC. He
will be a key person in our ongoing process of streamlining
production and logistics, and a crucial element in the further
strengthening of our sales organization and market reach, says
Hofseth BioCare CEO, Tor Erik Andersen.
For further information, please contact:
Tor Erik Andersen, CEO of Hofseth BioCare
ASA
Mob: +47 911 79 854
E-mail: tea@hofsethbiocare.no
Jon Olav Ødegård, CFO of Hofseth BioCare
ASA
Phone: +47 936 32 966
E-mail: joo@hofsethbiocare.no
About Hofseth BioCare ASA:
HBC is a Norwegian biotech company that offers
high-value ingredients and finished products for humans and pets.
The company is founded on the core values of sustainability,
traceability and optimal utilization of natural resources. Through
an innovative hydrolysis technology, HBC is able to preserve the
quality of salmon oil, proteins and calcium, prepared of fresh
salmon off-cuts. HBC's objective is to contribute to the efficient
use of marine resources and deliver quality products for
ingredients and finished consumer products in the nutrition
market.
Hofseth BioCare's headquarters are located in Ålesund, Norway with
branches in Oslo, Chicago, Mumbai and Tokyo. HBC is listed on Oslo
Stock Exchange Axess list with ticker "HBC". More information about
Hofseth BioCare at www.hofsethbiocare.com and
www.facebook.com/hofsethbiocare
This information is subject
of the disclosure requirements pursuant to section 5-12 of the
Norwegian Securities Trading Act.